Document Detail


Anticoagulant management in patients with atrial fibrillation.
MedLine Citation:
PMID:  19787557     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with a high risk of embolic stroke (cause in 15% of all strokes and 30% of strokes in those >75 years of age). Anticoagulation with warfarin will reduce stroke risk by about two thirds. The main risks of anticoagulation, namely bleeding, can be minimized by maintaining anticoagulation control within the international normalized range range of 2.0 to 3.0 (target: 2.5). To have a public health impact, patients with AF need efficient and correct identification, with appropriate treatment directed at those patients at most risk from the condition.
Authors:
David A Fitzmaurice; F D Richard Hobbs
Related Documents :
10582997 - Association between large aortic arch atheromas and high-intensity transient signals in...
19740487 - Predisposing factors for acute deterioration of minor ischemic stroke.
17721987 - Interventional stroke therapy: current state of the art and needs assessment.
12365647 - Stroke registry in kaohsiung veterans general hospital.
16519567 - Potential predictive patterns of minimal residual disease detected by immunohistochemis...
18398737 - Prognostic implications of the immunophenotype in biphenotypic acute leukemia.
Publication Detail:
Type:  Journal Article     Date:  2009-09-28
Journal Detail:
Title:  Seminars in thrombosis and hemostasis     Volume:  35     ISSN:  1098-9064     ISO Abbreviation:  Semin. Thromb. Hemost.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-09-29     Completed Date:  2010-01-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0431155     Medline TA:  Semin Thromb Hemost     Country:  United States    
Other Details:
Languages:  eng     Pagination:  543-7     Citation Subset:  IM    
Copyright Information:
Thieme Medical Publishers.
Affiliation:
University of Birmingham, Birmingham, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / therapeutic use*
Atrial Fibrillation / complications,  drug therapy*
Humans
Risk Factors
Stroke / etiology,  prevention & control
Chemical
Reg. No./Substance:
0/Anticoagulants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Improving antithrombotic management in patients with atrial fibrillation: current status and perspec...
Next Document:  Antithrombotic prophylaxis in elderly patients with atrial fibrillation.